Home Cart Sign in  
Chemical Structure| 34369-07-8 Chemical Structure| 34369-07-8

Structure of ATP disodium salt hydrate
CAS No.: 34369-07-8

Chemical Structure| 34369-07-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

ATP disodium salt hydrate (Adenosine 5'-triphosphate disodium salt hydrate) is a central component of energy storage and metabolism, providing metabolic energy to drive pumps and serving as a coenzyme in cells. It is an important endogenous signaling molecule in immunity and inflammation.

Synonyms: Adenosine 5'-triphosphate disodium salt hydrate; Adenosine disodium triphosphate hydrate; ATP disodium salt

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of ATP disodium salt hydrate

CAS No. :34369-07-8
Formula : C10H16N5O13P3Na2.xH2O
M.W : 569.16
SMILES Code : O[C@@H]([C@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)O)[C@H]3COP(O)(OP(OP([O-])([O-])=O)(O)=O)=O.[H]O[H].[Na+].[Na+]
Synonyms :
Adenosine 5'-triphosphate disodium salt hydrate; Adenosine disodium triphosphate hydrate; ATP disodium salt
MDL No. :MFCD00150755

Safety of ATP disodium salt hydrate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
neonatal rat cardiomyocytes 30 μM 24 hours To examine the effect of hyperglycemia on cardiac function and the expression of KATP channels. The results showed that high glucose concentration reduced the expression levels of SUR-2A and Kir6.2 PMC3274424

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Wistar rats STZ-induced diabetic rat model intravenous injection 25 mg/kg/day daily for 30 days To investigate the effect of diabetes on the expression of cardiac KATP channels. The results showed that the mRNA and protein expression levels of KATP channels were significantly decreased in the hearts of diabetic rats PMC3274424

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.76mL

0.35mL

0.18mL

8.78mL

1.76mL

0.88mL

17.57mL

3.51mL

1.76mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
 

Historical Records

Categories